This DVA effect appears to have been achieved by promoting the immune system because the CD4+ and CD8+ T cell numbers, when DVA was added to NAC treatment in the study by Li et al., were higher than numbers in mice with tumours or those treated with NAC without DVA. The gene discussed is CD4; the disease is neoplasm.